---
figid: PMC5467995__koni-06-05-1314424-g001
figlink: /pmc/articles/PMC5467995/figure/f0001/
number: Figure 1
caption: 'Major intracellular pathways leading to Type-I-IFN production. Families
  of sensors, known as PRRs, are available in the cells to detect viral and danger
  products, and induce the expression of Type-I-IFNs. One set of PRRs is localized
  in endosomal vesicles, while another set senses components in the cytoplasm. The
  endosome-associated TLR3 and the cytosolic MDA5, RIG-I and NOD2 sense double-stranded
  and single-stranded RNAs through the activation of adaptor molecules such as TRIF
  and MAVS, respectively. TRIF and MAVS in turn converge to activate the TBK1-IKKε
  kinase complex. This culminates in the activation of the transcription factors IRF3
  and IRF7, which translocate to the nucleus and participate in the induction of a
  first wave of IFN-β production (1). IFN-β in turn acts in an autocrine/paracrine
  manner binding to the heterodimeric receptor IFNAR1-IFNAR2. This is followed by
  the activation of a JAK-STAT signaling pathway leading to a second wave of IFN-α
  production as well as to the transcription of other antiviral genes (2). Other PRRs
  sensing DNA are DAI and cGAS, with this last catalyzing the formation of ligands
  for STING upstream of the TBK1-IKKε complex, which finally drives the expression
  of IFNA and IFNB. cGAMP, cyclic guanosine monophosphate-adenosine monophosphate;
  cGAS: cyclic GMP-AMP synthase; DAI: DNA-dependent activator of IRFs; IFNs: interferons;
  IFNAR: IFN-α/β receptor; IKKε: IkB kinase ε; IRF: IFN regulatory factor; ISGs: IFN-stimulated
  genes; JAK: Janus kinase; MAVS: mitochondrial antiviral signaling adaptor; MDA5:
  melanoma differentiation-associated protein 5; NOD2: nucleotide oligomerization
  domain 2; PRRs: pathogen recognition receptors; RIG-I: retinoic acid-inducible gene-I;
  STAT: signal transducer and activator of transcription; STING: stimulator of IFN
  genes; TBK1: TANK-binding kinase 1; TLR3: Toll-like receptor 3; TRIF: TIR-domain
  containing adaptor protein-inducing IFN-β; TYK2, tyrosine kinase-2.'
pmcid: PMC5467995
papertitle: 'Type-I-interferons in infection and cancer: Unanticipated dynamics with
  therapeutic implications.'
reftext: Martina Musella, et al. Oncoimmunology. 2017;6(5):e1314424.
pmc_ranked_result_index: '99683'
pathway_score: 0.9681082
filename: koni-06-05-1314424-g001.jpg
figtitle: Major intracellular pathways leading to Type-I-IFN production
year: '2017'
organisms: Homo sapiens
ndex: fd563072-decc-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5467995__koni-06-05-1314424-g001.html
  '@type': Dataset
  description: 'Major intracellular pathways leading to Type-I-IFN production. Families
    of sensors, known as PRRs, are available in the cells to detect viral and danger
    products, and induce the expression of Type-I-IFNs. One set of PRRs is localized
    in endosomal vesicles, while another set senses components in the cytoplasm. The
    endosome-associated TLR3 and the cytosolic MDA5, RIG-I and NOD2 sense double-stranded
    and single-stranded RNAs through the activation of adaptor molecules such as TRIF
    and MAVS, respectively. TRIF and MAVS in turn converge to activate the TBK1-IKKε
    kinase complex. This culminates in the activation of the transcription factors
    IRF3 and IRF7, which translocate to the nucleus and participate in the induction
    of a first wave of IFN-β production (1). IFN-β in turn acts in an autocrine/paracrine
    manner binding to the heterodimeric receptor IFNAR1-IFNAR2. This is followed by
    the activation of a JAK-STAT signaling pathway leading to a second wave of IFN-α
    production as well as to the transcription of other antiviral genes (2). Other
    PRRs sensing DNA are DAI and cGAS, with this last catalyzing the formation of
    ligands for STING upstream of the TBK1-IKKε complex, which finally drives the
    expression of IFNA and IFNB. cGAMP, cyclic guanosine monophosphate-adenosine monophosphate;
    cGAS: cyclic GMP-AMP synthase; DAI: DNA-dependent activator of IRFs; IFNs: interferons;
    IFNAR: IFN-α/β receptor; IKKε: IkB kinase ε; IRF: IFN regulatory factor; ISGs:
    IFN-stimulated genes; JAK: Janus kinase; MAVS: mitochondrial antiviral signaling
    adaptor; MDA5: melanoma differentiation-associated protein 5; NOD2: nucleotide
    oligomerization domain 2; PRRs: pathogen recognition receptors; RIG-I: retinoic
    acid-inducible gene-I; STAT: signal transducer and activator of transcription;
    STING: stimulator of IFN genes; TBK1: TANK-binding kinase 1; TLR3: Toll-like receptor
    3; TRIF: TIR-domain containing adaptor protein-inducing IFN-β; TYK2, tyrosine
    kinase-2.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IFNA5
  - IFNA1
  - IFNA4
  - IFNAR2
  - IFNB1
  - IFNA21
  - IFNA2
  - IFNA14
  - IFNA16
  - IFNA6
  - TLR3
  - IKBKE
  - IRF3
  - IFNA17
  - TMEM173
  - DDX58
  - STAT1
  - IFNAR1
  - IRF7
  - IFNA13
  - MAVS
  - IFNA7
  - STAT2
  - JAK1
  - CGAS
  - IFIH1
  - ZBP1
  - IFNA10
  - IFNA8
  - NOD2
genes:
- word: →IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA5
  entrez: '3442'
- word: →IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: →IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA4
  entrez: '3441'
- word: IFNAR2
  symbol: IFNAR2
  source: hgnc_symbol
  hgnc_symbol: IFNAR2
  entrez: '3455'
- word: →IFNB
  symbol: IFNB
  source: bioentities_symbol
  hgnc_symbol: IFNB1
  entrez: '3456'
- word: →IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA21
  entrez: '3452'
- word: →IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA2
  entrez: '3440'
- word: →IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA14
  entrez: '3448'
- word: →IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA16
  entrez: '3449'
- word: →IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA6
  entrez: '3443'
- word: TLR3
  symbol: TLR3
  source: hgnc_symbol
  hgnc_symbol: TLR3
  entrez: '7098'
- word: IKKE
  symbol: IKKE
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKE
  entrez: '9641'
- word: IRF3
  symbol: IRF3
  source: hgnc_symbol
  hgnc_symbol: IRF3
  entrez: '3661'
- word: →IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA17
  entrez: '3451'
- word: STING
  symbol: STING
  source: hgnc_alias_symbol
  hgnc_symbol: TMEM173
  entrez: '340061'
- word: RIG-I
  symbol: RIG-I
  source: hgnc_alias_symbol
  hgnc_symbol: DDX58
  entrez: '23586'
- word: STAT1
  symbol: STAT1
  source: hgnc_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: IFNAR1
  symbol: IFNAR1
  source: hgnc_symbol
  hgnc_symbol: IFNAR1
  entrez: '3454'
- word: IRF7
  symbol: IRF7
  source: hgnc_symbol
  hgnc_symbol: IRF7
  entrez: '3665'
- word: →IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA13
  entrez: '3447'
- word: MAVS
  symbol: MAVS
  source: hgnc_symbol
  hgnc_symbol: MAVS
  entrez: '57506'
- word: →IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA7
  entrez: '3444'
- word: STAT2
  symbol: STAT2
  source: hgnc_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: JAK1
  symbol: JAK1
  source: hgnc_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: CGAS
  symbol: CGAS
  source: hgnc_symbol
  hgnc_symbol: CGAS
  entrez: '115004'
- word: MDA5
  symbol: MDA-5
  source: hgnc_alias_symbol
  hgnc_symbol: IFIH1
  entrez: '64135'
- word: DAI
  symbol: DAI
  source: hgnc_alias_symbol
  hgnc_symbol: ZBP1
  entrez: '81030'
- word: →IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA10
  entrez: '3446'
- word: →IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA8
  entrez: '3445'
- word: NOD2
  symbol: NOD2
  source: hgnc_symbol
  hgnc_symbol: NOD2
  entrez: '64127'
chemicals: []
diseases: []
---
